Study to Assess AFM24 in Advanced Solid Cancers

Stopped Enrollment into expansion cohorts in Phase 2 part was terminated due to sponsor decision

Conditions

• Advanced Solid Tumor

Interventions

• DRUG: 14 mg AFM24
• DRUG: 40 mg AFM24
• DRUG: 80 mg AFM24
• DRUG: 160 mg AFM24
• DRUG: 320 mg AFM24
• DRUG: 480 mg AFM24
• DRUG: 720 mg AFM24

Sponsor

Affimed GmbH